力量發展(01277.HK)獲納入滬港通及深港通標的證券
格隆匯9月9日丨 力量發展(01277.HK)公吿,根據上海證券交易所於2024年9月九日公佈的《關於滬港通下港股通標的調整的通知》及深圳證券交易所於2024年9月9日公佈的《關於深港通下的港股通標的證券名單調整的公吿》,公司股份已分別獲納入為滬港通及深港通標的證券,均自2024年9月10日起生效。
股份均獲納入滬港通及深港通,允許中國內地合資格投資者分別經由上海證券交易所及深圳證券交易所直接投資於香港聯合交易所有限公司上市的股份。董事會相信,該納入將有助於擴大公司的股東基礎及增加股份交易流通量,從而提升股份投資價值及公司於資本市場的聲譽。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.